16 Minutes on the News #30: CRISPR for Covid Testing and FDA EUAs

Published on:

As calls for better, faster, cheaper, portable testing for COVID-19 disease are heard around the world — given the important role of test-trace-isolate in re-opening the economy! — the FDA recently issued an Emergency Use Authorization (EUA) for a CRISPR-based …

The post 16 Minutes on the News #30: CRISPR for Covid Testing and FDA EUAs appeared first on Andreessen Horowitz.

Read more    Source: a16z.com

Leave a Reply